- Molecules
- 16
MedsAcross lists 16 molecules linked to Maturity-onset diabetes of the young type 2, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- MetforminBiguanide11 presentations1 brandA10BA02
- GlipizideSulfonylurea8 presentations1 brandA10BB07
- PioglitazonePeroxisome Proliferator Receptor alpha Agonist6 presentations4 brandsA10BG03
- GlyburideOrphanSulfonylurea5 presentations1 brandA10BB01
- SitagliptinDipeptidyl Peptidase 4 Inhibitor10 presentations9 brandsA10BH01
- NateglinideGlinide2 presentationsA10BX03
- Insulin lisproBiologicInsulin [Chemical/Ingredient]20 presentations20 brandsA10AB04
- RepaglinideGlinide3 presentations5 brandsA10BX02
- AcarboseAlpha-Glucosidase Inhibitor3 presentationsA10BF01
- Insulin aspartBiologicInsulin Analog10 presentations14 brandsA10AB05
- Insulin glargineBiologicInsulin Analog11 presentations15 brandsA10AE04
- MiglitolAlpha-Glucosidase Inhibitor3 presentationsA10BF02
- Insulin humanBiologicInsulin6 presentations9 brandsA10AB01
- ExenatideGLP-1 Receptor Agonist4 presentations1 brandA10BJ01
- PramlintideAmylin Analog2 presentations1 brandA10BX05
- Insulin detemirBiologicInsulin [Chemical/Ingredient]1 presentation2 brandsA10AE05
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Maturity-onset diabetes of the young type 2?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.